Literature DB >> 23164796

[Cardiovascular risk of immigrants living in Spain according to origin and years of stay].

Maria Luisa Lozano Sánchez1, Mariano Leal Hernández, José Abellán Huerta, Purificación Gómez Jara, Enrique José Ortín Ortín, José Abellán Alemán.   

Abstract

OBJECTIVE: To assess whether there are differences in the immigrant population in terms of the years since their arrival in Spain and their geographical area of origin.
DESIGN: A cross-sectional study was conducted in three immigrant groups. PARTICIPANTS: The groups selected were: a group of Latin American immigrants (298), a group of North African immigrants (130) and a group from Eastern Europe (114). A control group of 100 from a Spanish population of similar age and sex was also included.
METHODS: Anthropometric variables were measured, including biochemical inflammatory markers, blood pressure and cardiovascular risk estimation according to the tables of the European Societies of Hypertension and Cardiology.
RESULTS: The cardiovascular risk of the three groups of immigrants is similar between them (added cardiovascular risk high or very high at 5.5% in Latin Americans, 4.3% in North Africans, and 1.6% in immigrants from eastern countries), but significantly lower than the Spanish control group (28%). After 8 years in Spain, cardiovascular risk increases in the three groups of immigrants, with those from North Africa and eastern countries being comparable to the Spanish group (added cardiovascular risk high or very high of 18.5% in North Africans, and 20% in group from eastern countries). This cardiovascular risk was higher than the other groups, including the Spanish control group (Latin American immigrants 48.7% vs 28% in Spanish group).
CONCLUSIONS: The cardiovascular risk of immigrants increases over the years in Spain, with this increase being higher if they come from Latin America. This increase becomes clinically significant after the 8 years of stay in Spain.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23164796     DOI: 10.1016/j.aprim.2012.10.003

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  4 in total

1.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

2.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

Review 3.  Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review.

Authors:  Maria Roura; Andreu Domingo; Juan M Leyva-Moral; Robert Pool
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

4.  Cardiovascular disease risk factors in Spain: A comparison of native and immigrant populations.

Authors:  Elena Rodriguez-Alvarez; Nerea Lanborena; Luisa N Borrell
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.